Alaunos Therapeutics, Inc.
TCRTNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $5.30M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.72$4.50
- Volume (live)
- -
- Avg. volume (3M)
- 14.27M
Alaunos Therapeutics (TCRT) Stock Price & Financial Analysis
Alaunos Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.31 - $2.99 |
|---|---|
| 52-Week High | $4.50 |
| 52-Week Low | $0.72 |
| Open | $2.81 |
| Volume (last close) | 32.04M |
| Average Volume (3M) | 14.27M |
| Revenue (TTM) | 3.00K |
|---|---|
| Net Income (TTM) | -4.01M |
| Free Cash Flow (TTM) | -2.82M |
| EPS (TTM) | −$1.88 |
| Profit Margin | -133666.67% |
| Operating Margin | -135266.67% |
| Return on Equity (ROE) | -615.03% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 5.30M |
|---|---|
| Shares Outstanding | 2.43M |
| Price to Sales (P/S) | 1767.03 |
| Price to Book (P/B) | 8.13 |
| EV/EBITDA | -1.30 |
| 50-Day MA | $1.51 |
|---|---|
| 200-Day MA | $2.37 |
| 1-Year Change | −28.99% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Alaunos Therapeutics at a Glance
As of the Oct 16, 2026 close, Alaunos Therapeutics (TCRT) has a market capitalization of $5.30M. The stock trades at 1767.0× sales. Over the trailing twelve months it lost $4.01M on revenue of $3.00K and burned $2.82M of free cash flow. Revenue fell 50.0% year over year.
As of its latest reported balance sheet, it holds $124.00K in cash and securities against $0.00 of debt, a net cash position of $124.00K.
Alaunos Therapeutics does not currently pay a dividend.
The share price is down 29.0% over the past year. At $2.63 (the Oct 16, 2026 close) it sits within its 52-week range of $0.72 to $4.50, above its 200-day moving average of $2.37.
Frequently Asked Questions About Alaunos Therapeutics
What is the current stock price for TCRT?
As of the Oct 16, 2026 close, TCRT stock trades at $2.63. The 52-week range is $0.72–$4.50, with a day range of $2.31–$2.99.
What is the P/E ratio for TCRT?
The P/E ratio (Price-to-Earnings) for TCRT is shown in the Key Statistics section. This valuation metric helps compare Alaunos Therapeutics, Inc. to industry peers.
Does TCRT pay dividends?
Alaunos Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TCRT?
Analyst ratings and recommendations for TCRT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TCRT?
As of the Oct 16, 2026 close, Alaunos Therapeutics's market capitalization is $6.4M, classifying it as a micro-cap company. Alaunos Therapeutics operates in the Healthcare sector within the Biotechnology industry.